Investing
Top Pre-Market Analyst Upgrades (AXYS, CRXL, DFT, LVLT, LGND, NOC, OXGN, PFE)
February 12, 2009 7:29 am
Last Updated: March 10, 2020 6:25 pm
These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens:
- Axsys Technologies (AXYS) Raised to Overweight at JPMorgan.
- Crucell (CRXL) Started as Buy at Jefferies.
- DuPont Fabros Technology (DFT) Raised to Outperform at Wachovia.
- Level 3 Communications (LVLT) Raised to Hold at Stanford.
- Ligand Pharmaceuticals (LGND) Started as Buy at Merriman Curhan Ford.
- Northrop Grumman (NOC) Raised to Outperform at Bernstein.
- Oxigene (OXGN) Started as Buy at Merriman Curhan Ford.
- Pfizer (PFE) Raised to Outperform at Leerink Swann.
Jon C. Ogg
February 12, 2009
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Editors' Picks
